Eli Lilly GLP-1 pill Foundayo approved for obesity
The U.S. Food and Drug Administration approved Eli Lilly‘s GLP-1 pill, the corporate stated, a significant milestone for the Indianapolis-based drugmaker and one that can take a look at the market for new weight-loss medicines. Lilly stated the once-daily pill, Foundayo, will begin transport from direct-to-consumer platform LillyDirect on Monday and might be accessible at…